133 related articles for article (PubMed ID: 35299026)
1. Phenolsulfonphthalein as a surrogate substrate to assess altered function of the prostaglandin transporter SLCO2A1.
Nakamura Y; Kozakai H; Nishio T; Yoshida K; Nakanishi T
Drug Metab Pharmacokinet; 2022 Jun; 44():100452. PubMed ID: 35299026
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3.
Gose T; Nakanishi T; Kamo S; Shimada H; Otake K; Tamai I
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():10-7. PubMed ID: 26692285
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin Transporter OATP2A1/
Nakamura Y; Nakanishi T; Shimada H; Shimizu J; Aotani R; Maruyama S; Higuchi K; Okura T; Deguchi Y; Tamai I
J Neurosci; 2018 Jun; 38(24):5584-5595. PubMed ID: 29899035
[TBL] [Abstract][Full Text] [Related]
4. Modulation of prostaglandin transport activity of SLCO2A1 by annexin A2 and S100A10.
Nakamura Y; Ito MA; Hoshino Y; Matsuoka I; Okada T; Okada Y; Nakanishi T
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1042-C1053. PubMed ID: 38372137
[TBL] [Abstract][Full Text] [Related]
5. N-glycosylation modifies prostaglandin E
Nakamura Y; Aizawa C; Kawata H; Nakanishi T
Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106714. PubMed ID: 36706979
[TBL] [Abstract][Full Text] [Related]
6. Toxicological implication of prostaglandin transporter SLCO2A1 inhibition by cigarette smoke in exacerbation of lung inflammation.
Nakanishi T; Sakiyama S; Takashima H; Honda R; Shumba MN; Nakamura Y; Kasahara K; Tamai I
Toxicol Appl Pharmacol; 2020 Oct; 405():115201. PubMed ID: 32828905
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.
Nakanishi T; Hasegawa Y; Mimura R; Wakayama T; Uetoko Y; Komori H; Akanuma S; Hosoya K; Tamai I
PLoS One; 2015; 10(4):e0123895. PubMed ID: 25923111
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of mutant SLCO2A1 transporters found in patients with chronic enteropathy associated with SLCO2A1.
Seki S; Tanaka G; Kimura T; Hayashida M; Miyoshi J; Matsuura M; Sakurai H; Hisamatsu T
J Gastroenterol Hepatol; 2022 Sep; 37(9):1776-1784. PubMed ID: 35877192
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy.
Jimbo K; Okuno T; Ohgaki R; Nishikubo K; Kitamura Y; Sakurai Y; Quan L; Shoji H; Kanai Y; Shimizu T; Yokomizo T
PLoS One; 2020; 15(11):e0241869. PubMed ID: 33166338
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action.
Nakanishi T; Nakamura Y; Umeno J
Pharmacol Ther; 2021 Jul; 223():107803. PubMed ID: 33465398
[TBL] [Abstract][Full Text] [Related]
11. Slco2a1 deficiency exacerbates experimental colitis via inflammasome activation in macrophages: a possible mechanism of chronic enteropathy associated with SLCO2A1 gene.
Nakata R; Nakamura Y; Hosomi S; Okuda H; Nishida Y; Sugita N; Itani S; Nadatani Y; Otani K; Tanaka F; Kamata N; Taira K; Nagami Y; Tanigawa T; Watanabe T; Yamagami H; Nakanishi T; Fujiwara Y
Sci Rep; 2020 Mar; 10(1):4883. PubMed ID: 32184453
[TBL] [Abstract][Full Text] [Related]
12. OATP2A1/SLCO2A1-mediated prostaglandin E2 loading into intracellular acidic compartments of macrophages contributes to exocytotic secretion.
Shimada H; Nakamura Y; Nakanishi T; Tamai I
Biochem Pharmacol; 2015 Dec; 98(4):629-38. PubMed ID: 26474801
[TBL] [Abstract][Full Text] [Related]
13. A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer.
Nakanishi T; Ohno Y; Aotani R; Maruyama S; Shimada H; Kamo S; Oshima H; Oshima M; Schuetz JD; Tamai I
Sci Rep; 2017 Nov; 7(1):16567. PubMed ID: 29185482
[TBL] [Abstract][Full Text] [Related]
14. Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.
Guda K; Fink SP; Milne GL; Molyneaux N; Ravi L; Lewis SM; Dannenberg AJ; Montgomery CG; Zhang S; Willis J; Wiesner GL; Markowitz SD
Cancer Prev Res (Phila); 2014 Aug; 7(8):805-12. PubMed ID: 24838973
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of chronic enteropathy associated with the
Xie ZX; Li Y; Yang AM; Wu D; Wang Q
World J Gastroenterol; 2024 May; 30(19):2505-2511. PubMed ID: 38817656
[TBL] [Abstract][Full Text] [Related]
16. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis.
Sasaki T; Niizeki H; Shimizu A; Shiohama A; Hirakiyama A; Okuyama T; Seki A; Kabashima K; Otsuka A; Ishiko A; Tanese K; Miyakawa S; Sakabe J; Kuwahara M; Amagai M; Okano H; Suematsu M; Kudoh J
J Dermatol Sci; 2012 Oct; 68(1):36-44. PubMed ID: 22906430
[TBL] [Abstract][Full Text] [Related]
17. Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy.
Cheng R; Li M; Guo Y; Yao Y; Gao C; Yao Z
Eur J Dermatol; 2013; 23(5):636-9. PubMed ID: 24153155
[TBL] [Abstract][Full Text] [Related]
18. A novel variant in the SLCO2A1 gene in a Chinese patient with chronic gastroenteropathy and primary hypertrophic osteoarthropathy.
Dai Y; He M; Xu H; Tan B; Zhou W; Liu W; Wang Q; Huang J; Shang Q; Liu Y; Li Y
Orphanet J Rare Dis; 2024 Jun; 19(1):229. PubMed ID: 38862970
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
J Clin Endocrinol Metab; 2013 May; 98(5):E923-33. PubMed ID: 23509104
[TBL] [Abstract][Full Text] [Related]
20. Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1.
Kamo S; Nakanishi T; Aotani R; Nakamura Y; Gose T; Tamai I
J Pharm Sci; 2017 Sep; 106(9):2483-2490. PubMed ID: 28479361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
